AARD (AARD) reported D&A of $11K in Q1 2026.

How has AARD's D&A changed year-over-year?

AARD's D&A increased by 120.0% year-over-year, from $5K to $11K.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

AARD AARD D&A

D&A at other companies

Aquestive Therapeutics, Inc.AQST

$113K-18.7%

ArvinasARVN

$700K0.0%

Protagonist TherapeuticsPTGX

$407K+70.3%

Arcus BiosciencesRCUS

$2M-33.3%

Other financials

Income statement

See full

Revenue-—

Operating income-$22.5M-115%

Net income-$21.6M-132%

EPS (diluted)-$0.99-39.4%

Balance sheet

See full

Cash & equivalents$62.4M+136%

Total debt$336.0K-53.7%

Total equity$87.0M-42.3%

Total assets$98.6M-37.2%

Cash flow

See full

Operating cash flow-$18.9M-65.7%

CapEx--100%

Free cash flow-$16.8M-117%

Valuation

See full

Market cap$124.35M-58.6%

Enterprise value$62.25M-77.4%

Returns & leverage

See full

Return on equity-58.8%—

Debt / equity0×0.0×

Current ratio8.1×-17.8×

Where this comes from

Reported directly by AARD in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AARD's D&A?: AARD (AARD) reported D&A of $11K in Q1 2026.
How has AARD's D&A changed year-over-year?: AARD's D&A increased by 120.0% year-over-year, from $5K to $11K.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.